More From Employee Benefit News
Forging stronger broker-TPA partnerships
Collaboration between employers, brokers and third-party administrators will be essential to developing customized, cost-effective and employee-friendly solutions.
Employers face a new GLP-1 question: Are the drugs worth it?
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
What Trump’s ‘Great Healthcare Plan’ means for drug costs and price transparency
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Healthcare costs are forcing employers to reconsider their benefits strategy
Employers are under pressure to keep benefits competitive while controlling costs, driving new scrutiny of PBMs, hospital prices and GLP-1 coverage for 2027.
Why payment integrity is a game changer
At a time of never-ending health benefit cost increases and fiduciary lawsuits, it has never been more important to ensure that claims are paid correctly.
